Spexin (Neuropeptide Q): Distribution, Functional Roles, and Emerging Therapeutic Perspectives
Ritesh S. Tarwani,
No information about this author
Kamini R. Shirasath,
No information about this author
Sanjay N. Awathale
No information about this author
et al.
International Journal of Peptide Research and Therapeutics,
Journal Year:
2025,
Volume and Issue:
31(2)
Published: Jan. 8, 2025
Language: Английский
The gut microbiota-inflammation-HFpEF axis: deciphering the role of gut microbiota dysregulation in the pathogenesis and management of HFpEF
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2025,
Volume and Issue:
15
Published: March 13, 2025
Heart
failure
with
preserved
left
ventricular
ejection
fraction
(HFpEF)
is
a
disease
that
affects
multiple
organs
throughout
the
body,
accounting
for
over
50%
of
heart
cases.
HFpEF
has
significant
impact
on
individuals’
life
expectancy
and
quality
life,
but
exact
pathogenesis
remains
unclear.
Emerging
evidence
implicates
low-grade
systemic
inflammation
as
crucial
role
in
onset
progression
HFpEF.
Gut
microbiota
dysregulation
associated
metabolites
alteration,
including
short-chain
fatty
acids,
trimethylamine
N-oxides,
amino
bile
acids
can
exacerbate
chronic
inflammatory
responses
potentially
contribute
to
In
light
these
findings,
we
propose
hypothesis
“gut
microbiota-inflammation-HFpEF
axis”,
positing
interplay
within
this
axis
could
be
factor
development
This
review
focuses
gut
dysregulation-induced
HFpEF’s
etiology.
It
explores
potential
mechanisms
linking
cardiac
dysfunction
evaluates
therapeutic
restoring
balance
mitigating
severity.
The
objective
offer
novel
insights
strategies
management
Language: Английский
Potential Probiotics for the Therapy of Metabolic Dysfunction-Associated Steatotic Liver Disease
Xiayun Li,
No information about this author
Liyan Yu,
No information about this author
Zong‐Gen Peng
No information about this author
et al.
IntechOpen eBooks,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 27, 2025
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD),
a
prevalent
metabolic
disorder
globally,
has
presented
an
urgent
need
for
effective
therapeutic
agents.
The
complex
pathogenesis
of
MASLD
and
the
failure
numerous
clinical
trials
targeting
this
have
prompted
exploration
probiotic
intervention
as
novel
strategy.
Emerging
evidence
underscores
pivotal
role
gut-liver
axis
in
progression,
particularly
through
dysregulation
gut
microbiota
composition,
impaired
intestinal
barrier
integrity,
aberrant
bacterial
metabolite
signaling.
Preclinical
studies
indicate
that
specific
strains
may
ameliorate
by
restoring
microbial
homeostasis,
fortifying
function,
attenuating
hepatic
inflammation
via
crosstalk.
Preliminary
further
support
beneficial
effects
probiotics
reducing
steatosis
improving
parameters.
Future
research
should
prioritize
elucidating
strain-specific
mechanisms,
optimizing
formulations,
addressing
challenges
related
to
long-term
efficacy,
safety,
personalized
regimens.
This
review
comprehensively
evaluates
current
on
applications
treatment
highlights
critical
directions
advancing
translational
field.
Language: Английский
Hesperidin improves cardiac fibrosis induced by β-adrenergic activation through modulation of gut microbiota
Xia Liu,
No information about this author
Weiwei Ju,
No information about this author
Erjiao Qiang
No information about this author
et al.
Journal of Pharmacology and Experimental Therapeutics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 103578 - 103578
Published: April 1, 2025
Language: Английский
Microbiota-Based Intervention Alleviates High-Fat Diet Consequences Through Host-Microbe Environment Remodeling
Lanlan Yi,
No information about this author
Zhipeng Li,
No information about this author
Hong Xu
No information about this author
et al.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(9), P. 1402 - 1402
Published: April 22, 2025
A
high-fat
diet
leads
to
metabolic
disturbances,
which
are
important
factors
in
the
development
of
obesity.
Gut
microbial
composition
and
diversity
altered
by
a
diet.
In
general,
resulted
increased
Firmicutes
abundance
decreased
alpha
diversity.
Bile
acids
(BAs)
involved
digestion
absorption
fats
small
intestine
also
substrates
microorganisms
with
bile
salt
hydrolase
(BSH)
activity.
High-fat
diets
(HFDs)
have
been
shown
alter
gut
microbiota
BA
profiles
murine
models.
Similarly,
probiotic
supplementation
reverses
HFD-induced
adverse
effects.
This
review
focuses
on
energy
characteristics
its
effects
body
weight,
plasma
lipid-related
biochemical
markers,
changes
microbiome
characteristics,
role
BAs.
The
regular
mechanism
affects
intestinal
microenvironment
was
attempted
be
found.
Language: Английский
Research Progress of Intestinal Flora in Colorectal Cancer
Wenli Wei,
No information about this author
Qing Zhang
No information about this author
Journal of Biosciences and Medicines,
Journal Year:
2024,
Volume and Issue:
12(03), P. 122 - 129
Published: Jan. 1, 2024
Colorectal
cancer,
as
a
common
malignant
tumor,
has
been
increasing
in
incidence
year
by
and
become
one
of
the
leading
causes
death
worldwide.
Meanwhile,
researchers
have
found
close
relationship
between
dysbiosis
gut
microbiota
colorectal
which
further
triggered
indepth
exploration
role
pathogenesis,
diagnosis,
treatment
cancer.
Studies
shown
that
there
are
specific
microbial
changes
cancer
tissues,
including
enrichment
or
depletion
certain
bacterial
species,
may
be
associated
with
tumor
growth,
invasion,
metastasis.
Additionally,
to
closely
linked
microenvironment,
immune
response,
chemotherapy
drug
metabolism,
other
factors.
In
this
context,
it
is
imperative
study
A
comprehensive
understanding
interaction
not
only
helpful
revealing
novel
mechanisms
development,
but
also
holds
promise
providing
new
strategies
targets
for
early
individualized
treatment,
prevention
This
review
aims
thoroughly
discuss
research
progress
its
compositional
characteristics,
occurrence
development
potential
clinical
applications.
The
goal
provide
references
insights
field.
Language: Английский
Dietary Polycan, a β‐glucan originating from Aureobasidium pullulansSM‐2001, attenuates high‐fat‐diet‐induced intestinal barrier damage in obese mice by modulating gut microbiota dysbiosis
Food Science & Nutrition,
Journal Year:
2024,
Volume and Issue:
12(8), P. 5824 - 5835
Published: May 26, 2024
Abstract
Various
metabolic
diseases
caused
by
a
high‐fat
diet
(HFD)
are
closely
related
to
gut
microbiota
dysbiosis
and
epithelial
barrier
dysfunction.
Polycan,
type
of
β‐glucan,
is
effective
in
treating
anti‐obesity
HFD.
However,
the
effect
Polycan
on
damage
still
unknown.
In
this
study,
effects
intestinal
were
investigated
using
HFD‐induced
obese
model
mice.
C57BL/6
mice
fed
HFD
for
12
weeks
treated
with
two
different
doses
(250
500
mg/kg)
orally
administered
during
9
12.
supplementation
increased
expression
tight
junction
genes
(zonula
occludens‐1,
occludin,
claudin‐3)
short‐chain
fatty
acid
(SCFA)
content
while
reducing
toxic
substances
(phenol,
p
‐cresol,
skatole).
Most
significantly,
enriched
SCFA‐producing
bacteria
(i.e.,
Phocaeicola
,
Bacteroides
Faecalibaculum
Oscillibacter
Lachnospiraceae,
Muribaculaceae),
decreased
Firmicutes/Bacteroidetes
ratio
substances‐producing
Olsenella
Clostridium
XVIII,
Schaedlerella
).
Furthermore,
microbial
functional
capacity
prediction
revealed
that
many
SCFA‐related
KEGG
enzymes
substance‐related
depleted.
These
findings
indicated
has
potential
alleviate
modulating
function
composition
microbiota.
Language: Английский
Evaluation of polysaccharides from Laetiporus sulphureus on the growth of gastrointestinal probiotics and in vitro digestion
Xinting Zhu,
No information about this author
Shan Lin,
No information about this author
Qi Wei
No information about this author
et al.
Frontiers in Sustainable Food Systems,
Journal Year:
2024,
Volume and Issue:
8
Published: Dec. 18, 2024
Introduction
Probiotics
can
improve
immune
responses
and
regulate
the
ecosystem
of
microorganisms
in
gastrointestinal
tract.
Methods
Three
primary
models,
including
Reparameterized
Gompertz,
Huang,
Baranyi
Roberts
models
were
evaluated
developed
to
investigate
effects
Laetiporus
sulphureus
polysaccharides
(LSP)
on
growth
Lactobacillus
plantarum,
Streptococcus
thermophilus,
Clostridium
tyrobutyricum
,
Bifidobacterium
adolescentis
.
Results
The
Huang
model
Gompertz
suitable
for
describing
C.
tyrobutyricum,
S.
B.
L.
plantarum
LSP
could
increase
population
fluid
environment
stomach
vitro.
Discussion
These
results
may
support
further
development
as
a
functional
food
or
additive
that
has
ability
preserve
digestive
tract
health.
Language: Английский